Recent insights into the pathobiology of innate immune deficiencies

Current Allergy and Asthma Reports

Volumn 11, Issue 5, 2011, Pages 369-377

  Rosenzweig, Sergio D ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Complement; Dendritic cells; Innate immunity; Macrophages; Natural killer cells; Neutrophils; NK cells; NKT cells; Opsonins; Pattern recognition receptors; Primary immunodeficiencies

Indexed keywords

BETA2 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; RAC2 PROTEIN;

ARTICLE; CELL FUNCTION; CHRONIC GRANULOMATOUS DISEASE; COMPLEMENT SYSTEM; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; DISEASE ASSOCIATION; GENE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; IFNGR1 GENE; IMMUNE DEFICIENCY; INNATE IMMUNE DEFICIENCY; INNATE IMMUNITY; IRF8 GENE; LEUKOCYTE ADHESION DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY TYPE 1; LEUKOCYTE ADHESION DEFICIENCY TYPE 3; MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE; MONONUCLEAR PHAGOCYTE; MYELOKATHEXIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEMO GENE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIMARY IMMUNE DEFICIENCY; RAC2 DEFICIENCY; STAT1 GENE; WARTS HYPOGAMMAGLOBULINEMIA INFECTION AND MYELOKATHEXIS SYNDROME;

ANIMALS; AUTOIMMUNITY; COMMON VARIABLE IMMUNODEFICIENCY; GENETIC DISEASES, INBORN; HUMANS; IMMUNITY, INNATE; LEUKOCYTES; ORGAN SPECIFICITY;

EID: 81055157031     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-011-0212-9     Document Type: Article

References (51)

1. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284 (5418):1313-8. Review. (Pubitemid 29289650)
2. Medzhitov R, Janeway Jr CA. Decoding the patterns of self and nonself by the innate immune system. Science. 2002;296 (5566):298-300. (Pubitemid 34303673)
3. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291-5. Review.
4. Bach E, Aguet M, Schriber R. The IFNgamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol. 1997;15:563-91. (Pubitemid 27169292)
5. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581-620. (Pubitemid 34293435)
6. Rosenzweig SD, Holland SM. Defects in the interferon-g and interleukin-12 pathways. Immunol Rev. 2005;203:38-47.
7. Zhang S-Y, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-a/b, IFN-g, and IFN-l in host defense. Immunol Rev. 2008;226:29-40.
8. Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon-gamma receptor 1 deficiencies. Lancet. 2004;364(9451):2113- 21. (Pubitemid 39626807)
9. de Beaucoudrey, Bustamante J, Cobat A, et al. Revisiting human IL-12Rb1 deficiency: a survey of 140 patients from 30 countries. Medicine 2011, in press.
10. Hanson EP, Monaco-Shawver L, Solt LA, et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122(6):1169-1177.e16.
11. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058-62. Epub 2007 Aug 5. (Pubitemid 47345590)
12. Puel A, Picard C, Lorrot M, et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol. 2008;180(1):647-54.
13. Chapgier A, Kong XF, Boisson-Dupuis S, Jouanguy E, Averbuch D, Feinberg J, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest. 2009;119(6):1502-1.
14. Rezaei N, Moazzami K, Aghamohammadi A, et al. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009;28(5):335-66.
15. Kawai T, Malech HL. WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol. 2009;16(1):20-6. Review.
16. Balabanian K, Levoye A, Klemm L, et al. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J Clin Invest. 2008;118(3):1074-84. (Pubitemid 351364615)
17. Etzioni A. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options. Adv Exp Med Biol. 2007;601:51-60.
18. Uzel G, Tng E, Rosenzweig SD, et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood. 2008;111(1):209-18.
19. Thomas C, Le Deist F, Cavazzana-Calvo M, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood. 1995;86:1629-35.
20. Bauer Jr TR, Allen JM, Hai M, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med. 2008;14(1):93-7.
21. Nelson EJ, Tuschong LM, Hunter MJ, et al. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency. Gene Ther. 2010;17(5):672-7.
22. Gazit Y, Mory A, Etzioni A, et al. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30(2):308-1.
23. Manevich-Mendelson E, Feigelson SW, Pasvolsky R, et al. Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 2009;114(11):2344-53.
24. Ambruso DR, Knall C, Abell AN, et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA. 2000;97:4654-9. (Pubitemid 30238613)
25. Routes JM, Grossman WJ, Verbsky J, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302 (22):2465-70.
26. Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170.
27. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363(27):2600-10.
28. Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114(15):3309-15.
29. Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28 Suppl 1:S67-72.
30. Roesler J. Carriers of X-linked chronic granulomatous disease at risk. Clin Immunol. 2009;130:233.
31. Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature. 2008;451(7175):211-5.
32. De Ravin SS, Zarember KA, Long-Priel D, et al. Tryptophan/ kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease. Blood. 2010 May 28.
33. Hartl D, Lehmann N, Hoffmann F, et al. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol. 2008;121(2):375-38.
34. Brown KL, Bylund J, MacDonald KL, et al. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol. 2008;129(1):90-10.
35. Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep. 2009;10(10):1103-10.
36. Sun JC, Lanier LL. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol. 2009;39(8):2059-64.
37. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol. 2006;6(6):399-409. (Pubitemid 44714151)
38. Diana J, Lehuen A. NKT cells: friend or foe during viral infections? Eur J Immunol. 2009;39(12):3283-91.
39. Kim HY, Eyheramonho MB, Pichavant M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest. 2011;121(3):1111-8.
40. Huck K, Feyen O, Niehues T, et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009;119(5):1350-8.
41. Locci M, Draghici E, Marangoni F, et al. The Wiskott-Aldrich syndrome protein is required for iNKTcell maturation and function. J Exp Med. 2009;206(4):735-42.
42. Kavanagh D, Richards A, Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med. 2008;59:293-309. (Pubitemid 351287939)
43. Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol. 2008;143(3):336-48.
44. Isnardi I, Ng YS, Menard L, et al. Complement receptor 2/ CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026-36.
45. Barrington RA, Schneider TJ, Pitcher LA, et al. Uncoupling CD21 and CD19 of the B-cell coreceptor. Proc Natl Acad Sci USA. 2009;106(34):14490-5.
46. Rakhmanov M, Keller B, Gutenberger S, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA. 2009;106(32):13451-6.
47. Browne SK, Holland SM. Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infectious Diseases 2011, in press.
48. Shikama N, Nusspaumer G, Holländer GA. Clearing the AIRE: on the pathophysiological basis of the autoimmune polyendocrinopathy syndrome type-1. Endocrinol Metab Clin North Am. 2009;38 (2):273-88.
49. Puel A, Döffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291-7.
50. Kisand K, Bøe Wolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207(2):299-308.
51. Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011 Feb 24 [Epub ahead of print].